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OBJECTIVE—We prospectively assessed the age- and sex-speciﬁc incidence and relative risk
of malignant neoplasm of the pancreas in Taiwan’s diabetic population.
RESEARCH DESIGN AND METHODS—A total of 615,532 diabetic patients and
614,871 age- and sex-matched control subjects were linked to inpatient claims (2000–2006)
to identify the admissions for malignant neoplasm of the pancreas (ICD-9: 157). The Cox pro-
portional hazards regression model was used to estimate the age- and sex-speciﬁcr el a t i v er is ko f
pancreatic neoplasm.
RESULTS—Compared with the control group, the diabetic patients had a signiﬁcantly in-
creased risk of pancreatic cancer (hazard ratio [HR] 1.54 [95% CI 1.39–1.71]). The higher and
signiﬁcantage-speciﬁcHRswereobservedindiabeticmen(1.91)and women(1.80)aged45–65
years.
CONCLUSIONS—Middle-aged diabetic men and women were associated with the most
increased risk of malignant neoplasm of the pancreas.
Diabetes Care 34:1177–1179, 2011
M
alignant neoplasm of the pan-
creas, a cancer with a high case-
fatalityrate(1),hasbeenobserved
to be associated with diabetes. Some
studies (2–6) reported that diabetes is
a risk factor for pancreatic cancer, but
others (7,8) concluded that diabetes is
simply a consequence of pancreatic can-
cer.Asaresultoffewercasesofpancreatic
cancer included in previous studies, most
o ft h ep r e v i o u sa n a l y s e sw e r eu n a b l et o
providereliableestimatesoftheincidence
rate and relative risk of malignant neo-
plasm of the pancreas in diabetes, accord-
ing to different age and sex stratiﬁcations.
Thecurrentstudyusedanationalcohort
retrieved from Taiwan’s National Health
Insurance database to prospectively
investigate the age- and sex-speciﬁc
incidence rates and relative risks of pan-
creatic cancer in Taiwan’sd i a b e t i cp o p -
ulation between 2000 and 2006.
RESEARCH DESIGN AND
METHODS—Details of claim data and
methods of selection of diabetic and
control groups were described in our
previousreport(9).Inbrief,anindividual
was classiﬁed as a diabetic patient if she
or he had an initial diabetes diagnosis
(ICD-9: 250 or a code 181) at any time
in 2000 and then experienced another
one or more diagnoses within the subse-
quent 12-month follow-up periods. The
ﬁrst and last outpatient visits within
1 year must be .30 days apart to avoid
accidentalinclusionofmiscodedpatients.
We further excluded those patients
admitted for malignant neoplasm (ICD-9:
140–208) during 1997–1999,resultingin
theﬁnaldiabeticcohortof615,532patients,
and the index date was the date of their
ﬁrst outpatient visit for diabetes in 2000.
A total of 614,871 age- and sex-
matched control subjects were randomly
selected from the registry of beneﬁciaries
after excluding those who were included
i nt h ed i a b e t i ca m b u l a t o r yc a r ec l a i mo r
hospitalized for any kind of malignancy
between 1997 and 1999. The index date
for control subjects was the ﬁrst day (for
those enrolled prior to 2000) or the ﬁrst
date of enrollment to the National Health
Insurance in 2000.
We linked study subjects in both
diabetic and control groups to the in-
patient claim data from 2000 to 2006 to
identify the possible onset of primary or
secondary diagnoses of malignant neo-
plasm of the pancreas (ICD-9: 157). To
account for the biologically relevant link
between diabetes and pancreatic cancer,
we retrieved only pancreatic neoplasm
admission 1 year after the index date. The
date of encountering pancreatic cancer
was the 1st day of hospitalization.
Theage-andsex-speciﬁchazard rates
were determined under the Poisson as-
sumption. To assess the independent ef-
fects of diabetes on the risks of malignant
neoplasm of the pancreas, we conducted
Cox proportional hazards regression mod-
els with age, sex, geographic area, urban-
ization statuses, and various gastric and
hepatobiliary comorbidities adjusted si-
multaneously in the model. All statistical
analyses were performed with SAS (ver-
sion 9.1; SAS Institute, Cary, NC). A
P value ,0.05 was considered statisti-
cally signiﬁcant.
RESULTS—The overall incidence den-
sityfordiabeticmenandwomenwas3.34
and 2.58 per 10,000 patient-years, re-
spectively, whereas the corresponding
ﬁgures for control men and women were
1.88 and 1.71 per 10,000 patient-years,
respectively. Irrespective of sex, the inci-
dence density increased with age in both di-
abetic and control groups, and the highest
incidence density was observed in those
aged .65 years.
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Epidemiology/Health Services Research
BRIEF REPORTCompared with the control subjects,
diabetic patients showed signiﬁcantly in-
creased risks of malignant neoplasm of
the pancreas, with an adjusted hazard
ratio (HR) of 1.54 (95% CI 1.39–1.71).
The adjusted HR was higher in diabetic
men (1.66 [1.44–1.91]) than in diabetic
women(1.43[1.23–1.65]). Because there
was a signiﬁcant interaction of diabetes
with age (P , 0.0001) for both men and
women, we performed the stratiﬁed ana-
lyses to estimate the age-speciﬁc HRs for
each sex. The higher and signiﬁcant age-
speciﬁc adjusted HRs were observed in
diabetic men and women aged 45–65
years (1.91 [1.52–2.39] and 1.80 [1.37–
2.36], respectively) (Table 1).
CONCLUSIONS—Compared with
the age- and sex-matched control group,
the incidence of malignant neoplasm of
the pancreas was higher in the diabetic
patients in all age and sex stratiﬁcations.
In addition, the incidence densities of
pancreatic neoplasm increased with age
irrespective of age and those aged .65
years had the highest incidence density
in both sexes. Meanwhile, the overall rel-
ative risk of pancreatic neoplasm was sig-
niﬁcantly increased in both male and
femalediabeticpatients,evenafteradjust-
ment for potential confounders. Gener-
ally, the relative risk of diabetic patients
noted in our study was comparable with
those of population-based cohort studies
(2,3,5,6). Although Chow et al. (2) indi-
cated that diabetic women had slightly
higher HRs of pancreatic cancer, our
study found that diabetic men had a
higher relative risk of pancreatic neo-
plasm, which was consistent with the re-
sults from some previous studies (3,5).
Because 69% of pancreatic cancers are di-
agnosedaftertheageof65years(1),there
were fewer cases of pancreatic cancers in
the middle-aged population. Thus, the
higher HR observed in middle-aged pa-
tients(i.e.,45–64years)couldbeattributed
to a low incidence density of pancreatic
cancer in middle-aged control subjects,
which also may be a valid argument for
a high but insigniﬁcant HR in young
(aged ,45 years) patients.
Although we could not differentiate
between type 1 and type 2 diabetes in our
study, type 1 diabetes constitutes only
1.8% of all diabetes in Taiwan (10).
Therefore, the majority of diabetic pa-
tients in our study are likely to be type 2
diabeticpatients.Thepossibleunderlying
biologic mechanism with which type 2
diabetes may cause malignant neoplasm
T
a
b
l
e
1
—
O
v
e
r
a
l
l
a
n
d
a
g
e
-
a
n
d
s
e
x
-
s
p
e
c
i
ﬁ
c
i
n
c
i
d
e
n
c
e
d
e
n
s
i
t
i
e
s
a
n
d
r
e
l
a
t
i
v
e
h
a
z
a
r
d
s
o
f
m
a
l
i
g
n
a
n
t
n
e
o
p
l
a
s
m
o
f
p
a
n
c
r
e
a
s
(
I
C
D
-
9
:
1
5
7
)
i
n
d
i
a
b
e
t
i
c
a
n
d
c
o
n
t
r
o
l
g
r
o
u
p
s
V
a
r
i
a
b
l
e
s
*
C
o
n
t
r
o
l
g
r
o
u
p
D
i
a
b
e
t
i
c
g
r
o
u
p
C
r
u
d
e
H
R
(
9
5
%
C
I
)
i
n
a
s
s
o
c
i
a
t
i
o
n
w
i
t
h
d
i
a
b
e
t
i
c
g
r
o
u
p
‡
A
d
j
u
s
t
e
d
H
R
(
9
5
%
C
I
)
i
n
a
s
s
o
c
i
a
t
i
o
n
w
i
t
h
d
i
a
b
e
t
i
c
g
r
o
u
p
§
P
a
t
i
e
n
t
s
(
n
)
E
v
e
n
t
s
(
n
)
I
n
c
i
d
e
n
c
e
d
e
n
s
i
t
y
(
p
e
r
1
0
,
0
0
0
p
a
t
i
e
n
t
-
y
e
a
r
s
)
(
9
5
%
C
I
)
†
P
a
t
i
e
n
t
s
(
n
)
E
v
e
n
t
s
(
n
)
I
n
c
i
d
e
n
c
e
d
e
n
s
i
t
y
(
p
e
r
1
0
,
0
0
0
p
a
t
i
e
n
t
-
y
e
a
r
s
)
(
9
5
%
C
I
)
†
M
e
n
A
g
e
(
y
e
a
r
s
)
,
4
5
4
0
,
5
3
7
7
0
.
2
6
(
0
.
0
7
–
0
.
4
5
)
4
0
,
5
3
7
1
4
0
.
5
4
(
0
.
2
6
–
0
.
8
3
)
2
.
1
0
(
0
.
8
5
–
5
.
8
1
)
1
.
9
2
(
0
.
7
6
–
4
.
8
9
)
4
5
–
6
5
1
4
1
,
8
9
9
1
2
0
1
.
2
8
(
1
.
0
5
–
1
.
5
1
)
1
4
1
,
8
9
9
2
2
2
2
.
4
6
(
2
.
1
4
–
2
.
7
8
)
1
.
9
3
(
1
.
5
5
–
2
.
4
1
)
1
.
9
1
(
1
.
5
2
–
2
.
3
9
)
.
6
5
1
1
3
,
1
2
7
1
9
3
2
.
6
6
(
2
.
2
8
–
3
.
0
3
)
1
1
3
,
1
2
9
2
5
6
3
.
7
1
(
3
.
2
5
–
4
.
1
6
)
1
.
4
0
(
1
.
1
6
–
1
.
6
9
)
1
.
4
7
(
1
.
2
1
–
1
.
7
7
)
T
o
t
a
l
2
9
5
,
5
6
3
3
2
0
1
.
8
8
(
1
.
6
8
–
2
.
0
7
)
2
9
5
,
5
6
6
4
9
2
3
.
3
4
(
3
.
0
8
–
3
.
6
0
)
1
.
6
2
(
1
.
4
0
–
1
.
8
6
)
1
.
6
6
(
1
.
4
4
–
1
.
9
1
)
W
o
m
e
n
A
g
e
(
y
e
a
r
s
)
,
4
5
2
9
,
0
8
0
2
0
.
1
0
(
2
0
.
0
4
t
o
0
.
2
5
)
2
9
,
0
7
9
1
0
0
.
5
4
(
0
.
2
1
–
0
.
8
7
)
5
.
1
5
(
1
.
1
3
–
2
3
.
5
0
)
4
.
4
6
(
0
.
9
6
–
2
0
.
7
0
)
4
5
–
6
5
1
5
4
,
9
1
1
8
3
0
.
8
1
(
0
.
6
3
–
0
.
9
8
)
1
5
4
,
9
1
1
1
4
2
1
.
4
3
(
1
.
2
0
–
1
.
6
7
)
1
.
7
8
(
1
.
3
6
–
2
.
3
4
)
1
.
8
0
(
1
.
3
7
–
2
.
3
6
)
.
6
5
1
3
5
,
3
1
7
2
3
2
2
.
6
2
(
2
.
2
8
–
2
.
9
5
)
1
3
5
,
3
1
8
2
7
4
3
.
2
3
(
2
.
8
5
–
3
.
6
1
)
1
.
2
4
(
1
.
0
4
–
1
.
4
7
)
1
.
2
6
(
1
.
0
6
–
1
.
5
1
)
T
o
t
a
l
3
1
9
,
3
0
8
3
1
7
1
.
7
1
(
1
.
5
4
–
1
.
8
9
)
3
1
9
,
3
1
0
4
2
6
2
.
5
8
(
2
.
3
6
–
2
.
8
0
)
1
.
4
0
(
1
.
2
1
–
1
.
6
2
)
1
.
4
3
(
1
.
2
3
–
1
.
6
5
)
O
v
e
r
a
l
l
6
1
4
,
8
7
1
6
3
7
1
.
7
9
(
1
.
6
6
–
1
.
9
2
)
6
1
5
,
5
3
2
9
1
8
2
.
9
4
(
2
.
7
7
–
3
.
1
1
)
1
.
5
1
(
1
.
3
6
–
1
.
6
7
)
1
.
5
4
(
1
.
3
9
–
1
.
7
1
)
D
a
t
a
a
r
e
H
R
(
9
5
%
C
I
)
u
n
l
e
s
s
o
t
h
e
r
w
i
s
e
i
n
d
i
c
a
t
e
d
.
*
I
n
c
o
n
s
i
s
t
e
n
c
y
b
e
t
w
e
e
n
t
o
t
a
l
p
o
p
u
l
a
t
i
o
n
a
n
d
p
o
p
u
l
a
t
i
o
n
s
u
m
m
e
d
f
o
r
i
n
d
i
v
i
d
u
a
l
v
a
r
i
a
b
l
e
w
a
s
a
r
e
s
u
l
t
o
f
m
i
s
s
i
n
g
i
n
f
o
r
m
a
t
i
o
n
.
†
B
a
s
e
d
o
n
t
h
e
P
o
i
s
s
o
n
a
s
s
u
m
p
t
i
o
n
.
‡
B
a
s
e
d
o
n
C
o
x
p
r
o
p
o
r
t
i
o
n
a
l
h
a
z
a
r
d
s
r
e
g
r
e
s
s
i
o
n
w
i
t
h
o
u
t
a
d
j
u
s
t
m
e
n
t
.
§
B
a
s
e
d
o
n
C
o
x
p
r
o
p
o
r
t
i
o
n
a
l
h
a
z
a
r
d
s
r
e
g
r
e
s
s
i
o
n
w
i
t
h
a
d
j
u
s
t
m
e
n
t
f
o
r
a
g
e
,
s
e
x
,
a
n
d
g
e
o
g
r
a
p
h
i
c
a
r
e
a
a
n
d
u
r
b
a
n
i
z
a
t
i
o
n
s
t
a
t
u
s
;
s
t
a
t
u
s
o
f
h
e
p
a
t
i
t
i
s
B
,
h
e
p
a
t
i
t
i
s
C
,
c
h
o
l
e
c
y
s
t
i
t
i
s
,
c
h
o
l
a
n
g
i
t
i
s
,
c
h
o
l
e
l
i
t
h
i
a
s
i
s
,
c
h
o
l
e
d
o
c
h
o
l
i
t
h
i
a
s
i
s
,
c
h
o
l
e
c
y
s
t
e
c
t
o
m
y
,
g
a
s
t
r
i
c
u
l
c
e
r
,
a
n
d
d
u
o
d
e
n
a
l
u
l
c
e
r
;
a
n
d
g
a
s
t
r
e
c
t
o
m
y
.
1178 DIABETES CARE, VOLUME 34, MAY 2011 care.diabetesjournals.org
Diabetes and pancreatic neoplasmof the pancreas has not been fully eluci-
dated. Insulin resistance and accompa-
nying compensatory hyperinsulinemia
might increase local blood ﬂow and cell
division in the pancreas (11). They also
might promote the growth of pancreatic
cell lines (12).
In conclusion, over a 7-year study pe-
riod, diabetic men and women in Taiwan
were observed to experience signiﬁcantly
increased risks of malignant neoplasm of
the pancreas. Diabetic men and women
aged 45–65 years were found to experi-
encethemostincreasedage-speciﬁcHRs.
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